The psychiatrist and founder of the Stuttering Treatment and Research Society discussed the historical persistence of stuttering, treatment gaps, and the nuances of managing psychiatric comorbidities. [WATCH TIME: 3 minutes]
Gerald Maguire, MD
Advertisement
Articles by Gerald Maguire, MD
The founder of the Stuttering Treatment and Research Society (STARS) discussed the unmet needs in stuttering care, current management strategies, and the mission of STARS to drive education, collaboration, and treatment development.
The founder of the Stuttering Treatment and Research Society (STARS) detailed current therapeutic strategies for stuttering, the role of dopamine pathways, and the pressing need for FDA-approved options. [WATCH TIME: 4 minutes]
Advertisement
Latest Updated Articles
Exploring the Unmet Need for FDA-Approved Therapies in Stuttering: Gerald Maguire, MDPublished: September 18th 2025 | Updated:
Stuttering, Research, and the Push for FDA-Approved Therapies: A Conversation With Gerald Maguire, MDPublished: September 19th 2025 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
CALLIPER Subpopulation Data Support Therapeutic Effect of Vidofludimus Calcium in Primary Progressive MS
2
Phase 3 Topline Results Show Rituximab Noninferior to Cladribine in Reducing New or Enlarging Brain Lesions in Relapsing-Remitting MS
3
Phase 2a INFORM-MS Trial to Study Anti-CD3 Agent Foralumab in Nonactive Secondary Progressive MS
4
Leveraging Artificial Intelligence to Extract Real-World Insights in Multiple Sclerosis: Rebekah Foster, MBA, and John Foley, MD, FAAN
5
